Paper
0
The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM
Authors
Tomohiro Koga,Keita Fujikawa
Yoshiro Horai,Akira Okada,Shin‐ya Kawashiri,Noriyuki Iwamoto,Takahisa Suzuki,Yoshikazu Nakashima,Mami Tamai,Kazuhiko Arima,Satoshi Yamasaki,Hidetoshi Nakamura,Tomoki Origuchi,Y. Hamaguchi,Manabu Fujimoto,Yuji Ishimatsu,Hiroshi Mukae,Masataka Kuwana,S Kohno,Katsumi Eguchi,Kiyoshi Aoyagi,Atsushi Kawakami
+20 authors
,Κει ArimaJournal
Published
Feb 29, 2012
Show more
Save
Tip0
TipSave
Abstract
Objective. Interstitial lung disease (ILD), especially rapidly progressive ILD (RPILD), is a major poor prognostic factor in patients with DM. We investigated the association of anti-melanoma differentiation-associated gene 5 (MDA5) antibody (Ab) with clinical characteristics and mortality in Japanese patients with DM.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.